Trump edging closer to appointing supporters of antiaging treatments to lead FDA
by noreply@blogger.com (brian wang) from NextBigFuture.com on (#28TA1)
President-elect Donald Trump met on Thursday with two Silicon Valley associates of billionaire tech investor Peter Thiel for potential roles in the Food and Drug Administration.
Trump will meet with entrepreneur Balaji Srinivasan and Jim O'Neill, a former Health and Human Services official under President George W. Bush, for roles in the Food and Drug Administration, Trump spokesman Sean Spicer said.
Both have deep ties to the tech world, as well as to Thiel, a Trump adviser and transition team member.
Srinivasan, who founded a genomic testing company, works at the venture capital firm Andreessen Horowitz, an influential player in Silicon Valley. Thiel had previously donated to a bitcoin startup launched by Srinivasan, according to The Washington Post.
Srinivasan has criticized how the FDA is run, sending several tweets in March that posed the regulators as an obstacle to innovation.
O'Neill works at Mithril Capital Management, where Thiel is a co-founder. FDA watchdogs have been alarmed by O'Neill's past comments, which include questioning whether the FDA should judge drugs' efficacy and support for organ sales.
In December, Nextbigfuture covered Jim O'Neill
Read more
Trump will meet with entrepreneur Balaji Srinivasan and Jim O'Neill, a former Health and Human Services official under President George W. Bush, for roles in the Food and Drug Administration, Trump spokesman Sean Spicer said.
Both have deep ties to the tech world, as well as to Thiel, a Trump adviser and transition team member.
Srinivasan, who founded a genomic testing company, works at the venture capital firm Andreessen Horowitz, an influential player in Silicon Valley. Thiel had previously donated to a bitcoin startup launched by Srinivasan, according to The Washington Post.
Srinivasan has criticized how the FDA is run, sending several tweets in March that posed the regulators as an obstacle to innovation.
O'Neill works at Mithril Capital Management, where Thiel is a co-founder. FDA watchdogs have been alarmed by O'Neill's past comments, which include questioning whether the FDA should judge drugs' efficacy and support for organ sales.
In December, Nextbigfuture covered Jim O'Neill
Read more